Commitments and Contingencies - Additional Information (Details) - USD ($) |
1 Months Ended | 6 Months Ended | 12 Months Ended |
|---|---|---|---|
Jan. 31, 2026 |
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Surety Bonds | |||
| Commitments And Contingencies [Line Items] | |||
| Maximum loan availability | $ 57,200,000 | $ 46,600,000 | |
| Bonds expiration period | Dec. 31, 2030 | ||
| Antelope Valley Medical Center v. CFC Health Plan, Inc. Arbitration | |||
| Commitments And Contingencies [Line Items] | |||
| Paid settlements | $ 1,000,000 | 12,000,000 | |
| Amounts remained payable | $ 0 | ||
| APC | Standby Letters of Credit | |||
| Commitments And Contingencies [Line Items] | |||
| Maximum loan availability | $ 27,500,000 | $ 27,900,000 | |
| Term of facility | 1 year | ||
| AHMS | Antelope Valley Medical Center v. CFC Health Plan, Inc. Arbitration | |||
| Commitments And Contingencies [Line Items] | |||
| Purchase price | $ 14,000,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Date the credit facility terminates, in YYYY-MM-DD format. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Period remaining on line of credit facility before it terminates, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|